Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

May 12, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • immunity

Tag: immunity

  • Biotechnopedia
  • DNA-Tales

Root Microbiome and its Ecological Functions

DNA tales September 15, 2021September 16, 2021

Srabani Roy Chowdhury, MAKAUT, WB Introduction Plant roots are associated with a diverse community of microorganisms. These communities are collectively known as root microbiome. The communities contain microorganisms that are both helpful as well as harmful for the plant, in terms of affecting its physiological functioning. Mycorrhizal and mycoparasitic fungi as well as bacteria that […]

Read More
  • BiotechToday
  • World

Inborn errors of immunity & corresponding protein interactions

bioxone August 18, 2021August 18, 2021

Avani Dave, Jai Hind College Inborn errors of immunity (IEI) are a group of approximately 400 monogenic diseases characterized by recurring, severe, or uncommon infections, as well as autoimmunity and autoinflammation. The synthesis of the clinical phenotype, the findings of immunological testing, and the results of genetic testing have identified the main pathogenic mutations required […]

Read More
  • BiotechToday
  • World

Natural killer cells: Defence against self-destruction

DNA tales August 7, 2021August 6, 2021 3

Kanikah Mehndiratta, MSc, University of Glasgow The human body encounters different types of pathogenic microbes and stressful events that can cause infection and convert normal cells into tumour cells. Our immune system has the ability to recognize and potentially eradicate such tumorous cells or any other cells working aberrantly. Mainly it’s the killer lymphocytes that […]

Read More
  • BiotechToday
  • World

Geminivirus and its host: A dynamic relationship

bioxone July 11, 2021July 10, 2021 1

Monika R, PSG College of Technology, Coimbatore Geminiviruses are plant viruses that cause economically important plant diseases worldwide. These viruses are proliferating globally and have attracted considerable scientific interest during the past 30 years. These viruses have circular ssDNA genomes and initiate infection with the discharge of viral ssDNA into the nucleus of the host, […]

Read More
  • BiotechToday
  • World

COVID-19 vaccine in Immunocompromised individuals.

bioxone July 10, 2021July 9, 2021 1

Avani Dave, Jai Hind College A recent study conducted by Satveer Mahil et al., showcased in the current year’s European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) and published in The Lancet Rheumatology, demonstrates that it is not the response of T-cell but that of the antibody to the first jab of the Pfizer […]

Read More
  • BiotechToday
  • World

Longer gap between vaccine doses: Effective or not?

BioTech Today July 8, 2021July 7, 2021

Anjali Kumari, IILM College of Engineering and Technology Longer gap (up to 45 weeks) between the Covid-19 vaccines may increase the immune response. According to a new study from the University of Oxford in the United Kingdom, it has been stated that a gap of up to 45 weeks between the first and second doses […]

Read More
  • BiotechToday
  • World

Egg-based influenza virus vaccines – Are they effective?

BioTech Today July 6, 2021July 5, 2021 3

Deivayanai. V.C , Rajalakshmi Engineering College Many countries across the globe have huge vaccine-producing factories for making vaccine shots. Certain vaccines are being made where influenza viruses are injected into chicken eggs. These eggs produce a high copy of the viruses. Production workers then extract the viruses from the egg, reduce the virulence or kill them […]

Read More
  • BiotechToday
  • World

A potential Covid vaccine for Multiple Myeloma Patients

BioTech Today July 4, 2021July 4, 2021 3

Saptaparna Dasgupta, Bennett University The risk of COVID19 infection is exceeded in multiple myeloma patients. Vaccine for the general population with BNT162b2 mRNA COVID19 (BNT162b2) provides effective protection against COVID19. However, their efficacy on patients with multiple myeloma may be adversely affected by and not yet assessed due to factors related to disease and therapy. […]

Read More
  • BiotechToday
  • India
  • World

Pfizer and Moderna: Long-Lasting Protection Against COVID-19

bioxone June 30, 2021July 5, 2021 1

Saptaparna Dasgupta, Bennett University A recently published new study states that both the Pfizer-BioNTech and Moderna COVID-19 vaccine immune system reactions have proved to offer long-lasting protection against COVID-19. mRNA vaccines have created more and better germinal centre B cell responses, thus indicating that the immunity system would be much more impactful and offer long-lasting […]

Read More
  • BiotechToday
  • World

PARP inhibitors: One class of drugs for Multiple Forms of Cancer

bioxone June 10, 2021June 10, 2021 3

Sayak Banerjee, Amity University Kolkata Scientists have come over a class of drugs utilized in the treatment of breast and ovarian cancer which might be effective in other types of diseases with inadequate treatment alternatives. These are called PARP inhibitors which have the potential to kill cancer cells carrying a defect in the Polybromo 1(PBRM1) […]

Read More

Posts navigation

1 2 3 4

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy